{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:40:36Z","timestamp":1770457236382,"version":"3.49.0"},"reference-count":22,"publisher":"Medknow","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Mycobacteriol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijmy.ijmy_122_19","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T13:02:53Z","timestamp":1574341373000},"page":"374","source":"Crossref","is-referenced-by-count":2,"title":["Biochemical value dynamics in patients with multidrug-resistant tuberculosis\/hiv with CD4+ lymphocyte cells below 50 cells\/\u03bcCL and its variability in the application of adjuvant immunoglobulin therapy"],"prefix":"10.4103","volume":"8","author":[{"given":"PetroB","family":"Antonenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NinaA","family":"Matsegora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AntoninaV","family":"Kaprosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/2212-5531.271463-1","unstructured":"World Health Organization. Global Tuberculosis Control Report. World Health Organization Report WHO. Geneva, Switzerland: World Health Organization; 2018."},{"key":"key-10.4103\/2212-5531.271463-2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15407\/microbiolj78.02.103","article-title":"Clusters of Mycobacterium tuberculosis genotypes in Odesa region","author":"Antonenko","year":"2016","journal-title":"Mikrobiol Z"},{"key":"key-10.4103\/2212-5531.271463-3","first-page":"30","article-title":"Mutations leading to drug-resistant Mycobacterium tuberculosis infection in ukraine","author":"Antonenko","year":"2010","journal-title":"Cent Eur J Med"},{"key":"key-10.4103\/2212-5531.271463-4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijmyco.2012.01.005","article-title":"Time series cross-correlation analysis of HIV seropositivity and pulmonary tuberculosis among migrants entering Kuwait","author":"Akhtar","year":"2012","journal-title":"Int J Mycobacteriol","ISSN":"https:\/\/id.crossref.org\/issn\/2212-5531","issn-type":"print"},{"key":"key-10.4103\/2212-5531.271463-5","first-page":"157","article-title":"High rates of human immunodeficiency virus and drug resistance in tuberculosis patients in Manila, Philippines","author":"Solante","year":"2017","journal-title":"Biomed Biotechnol Res J","ISSN":"https:\/\/id.crossref.org\/issn\/2588-9834","issn-type":"print"},{"key":"key-10.4103\/2212-5531.271463-6","doi-asserted-by":"crossref","first-page":"e0181004","DOI":"10.1371\/journal.pone.0181004","article-title":"The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-the women's interagency HIV study","author":"Keating","year":"2017","journal-title":"PLoS One"},{"key":"key-10.4103\/2212-5531.271463-7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/infdis\/jiz252","article-title":"Plasma biomarkers of human immunodeficiency virus-related systemic inflammation and immune activation in Sub-Saharan Africa before and during suppressive antiretroviral therapy","author":"Kroeze","year":"2019","journal-title":"J Infect Dis"},{"key":"key-10.4103\/2212-5531.271463-8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/ijmy.ijmy_66_19","article-title":"Evaluation Of Apoptotic Protease-Activating Factor-1 And Cluster Of Differentiation-4+ T-Cell Counts In Patients-Infected With Mycobacterium tuberculosis in Bauchi, Nigeria","author":"Shehu","year":"2019","journal-title":"Int J Mycobacteriol","ISSN":"https:\/\/id.crossref.org\/issn\/2212-5531","issn-type":"print"},{"key":"key-10.4103\/2212-5531.271463-9","doi-asserted-by":"crossref","first-page":"R247","DOI":"10.1186\/cc13073","article-title":"Kinetics of circulating immunoglobulin M in sepsis: Relationship with final outcome","author":"Giamarellos-Bourboulis","year":"2013","journal-title":"Crit Care"},{"key":"key-10.4103\/2212-5531.271463-10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/0022034511399915","article-title":"Immune reconstitution inflammatory syndrome","author":"Tappuni","year":"2011","journal-title":"Adv Dent Res"},{"key":"key-10.4103\/2212-5531.271463-11","first-page":"120","article-title":"Immunoglobulin therapy for sepsis","author":"Maltsev","year":"2016","journal-title":"Surg Ukraine"},{"key":"key-10.4103\/2212-5531.271463-12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/eji.200838630","article-title":"Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease","author":"Seddiki","year":"2009","journal-title":"Eur J Immunol"},{"key":"key-10.4103\/2212-5531.271463-13","first-page":"CD001090","article-title":"Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock","author":"Alejandria","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/2212-5531.271463-14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/CCM.0000000000000100","article-title":"Immunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: A longitudinal study*","author":"Gomez","year":"2014","journal-title":"Crit Care Med"},{"key":"key-10.4103\/2212-5531.271463-15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/QAD.0000000000002101","article-title":"Associations between baseline biomarkers and lung function in HIV-positive individuals","author":"MacDonald","year":"2019","journal-title":"AIDS"},{"key":"key-10.4103\/2212-5531.271463-16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10096-011-1413-9","article-title":"The immune reconstitution inflammatory syndrome related to HIV co-infections: A review","author":"Huis","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.4103\/2212-5531.271463-17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/bbrj.bbrj_50_19","article-title":"Coinfection between human immunodeficiency virus and tuberculosis: A consideration on ritonavir-related heme Oxygenase-1 pathway","author":"Sriwijitalai","year":"2019","journal-title":"Biomed Biotechnol Res J","ISSN":"https:\/\/id.crossref.org\/issn\/2588-9834","issn-type":"print"},{"key":"key-10.4103\/2212-5531.271463-18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijmyco.2014.02.004","article-title":"Active tuberculosis case finding and detection of drug resistance among HIV-infected patients: A cross-sectional study in a TB endemic area, Gondar, Northwest Ethiopia","author":"Alemayehu","year":"2014","journal-title":"Int J Mycobacteriol","ISSN":"https:\/\/id.crossref.org\/issn\/2212-5531","issn-type":"print"},{"key":"key-10.4103\/2212-5531.271463-19","first-page":"1","article-title":"The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles","author":"Young","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.4103\/2212-5531.271463-20","first-page":"51","article-title":"Haematological and biochemical disorders in tuberculosis\/HIV co-infected patients with different state of immunity","author":"Korzh","year":"2013","journal-title":"Tuberculosis"},{"key":"key-10.4103\/2212-5531.271463-21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.22141\/2224-0586.6.61.2014.83653","article-title":"Systemic inflammatory response syndrome peculiarities in patients with HIV\/AIDS-associated tuberculosis","author":"Shalmin","year":"2014","journal-title":"Emerg Med"},{"key":"key-10.4103\/2212-5531.271463-22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/ijmy.ijmy_41_19","article-title":"Risk factors associated with unsuppressed viral load in HIV-1 infected patients at the first antiretroviral therapy in Morocco","author":"Hicham","year":"2019","journal-title":"Int J Mycobacteriol","ISSN":"https:\/\/id.crossref.org\/issn\/2212-5531","issn-type":"print"}],"container-title":["International Journal of Mycobacteriology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T06:11:24Z","timestamp":1695449484000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ijmyco.org\/text.asp?2019\/8\/4\/374\/271463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["271463"],"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_122_19","relation":{},"ISSN":["2212-5531"],"issn-type":[{"value":"2212-5531","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}